129 related articles for article (PubMed ID: 1008865)
1. Guanidino compounds in the sera of uremic patients and in the sera and brain of experimental uremic rabbits.
Matsumoto M; Kishikawa H; Mori A
Biochem Med; 1976 Aug; 16(1):1-8. PubMed ID: 1008865
[No Abstract] [Full Text] [Related]
2. Guanidino compound levels in brain regions of non-dialyzed uremic patients.
De Deyn PP; Marescau B; D'Hooge R; Possemiers I; Nagler J; Mahler C
Neurochem Int; 1995 Sep; 27(3):227-37. PubMed ID: 8520461
[TBL] [Abstract][Full Text] [Related]
3. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A
Nephron; 1990; 54(4):307-12. PubMed ID: 2325795
[TBL] [Abstract][Full Text] [Related]
4. Ion-exchange chromatographic separation and fluorometric detection of guanidino compounds in physiologic fluids.
Yamamoto Y; Manji T; Saito A; Maeda K; Ohta K
J Chromatogr; 1979 Mar; 162(3):327-40. PubMed ID: 43330
[TBL] [Abstract][Full Text] [Related]
5. Determination of guanidino compounds by anion-exchange chromatography and amperometric detection.
Ding WD; Veening H; Van Effen RM
J Chromatogr; 1990 Apr; 526(2):355-66. PubMed ID: 2361978
[TBL] [Abstract][Full Text] [Related]
6. Endogenous guanidino compounds as uremic neurotoxins.
De Deyn PP; D'Hooge R; Van Bogaert PP; Marescau B
Kidney Int Suppl; 2001 Feb; 78():S77-83. PubMed ID: 11168988
[TBL] [Abstract][Full Text] [Related]
7. Determination of methylguanidine in serum and urine from normal and uremic subjects.
Menichini GC; Gonella M; Barsotti G; Giovannetti S
Experientia; 1971 Oct; 27(10):1157-8. PubMed ID: 5127860
[No Abstract] [Full Text] [Related]
8. Ontogenetic differences in convulsive action and cerebral uptake of uremic guanidino compounds in juvenile mice.
D'Hooge R; Pei YQ; Marescau B; De Deyn PP
Neurochem Int; 1994 Mar; 24(3):215-20. PubMed ID: 8025530
[TBL] [Abstract][Full Text] [Related]
9. Automatic system for the assay of guanidino compounds to assess uremic status and effect of hemodialysis.
Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T
Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1844-5. PubMed ID: 9845964
[TBL] [Abstract][Full Text] [Related]
10. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.
D'Hooge R; Pei YQ; Marescau B; De Deyn PP
J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446
[TBL] [Abstract][Full Text] [Related]
11. Automatic system for the assay of guanidino compounds to assess uremic status.
Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T; Watanabe M
Biol Pharm Bull; 2000 Sep; 23(9):1015-20. PubMed ID: 10993196
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of guanidino compounds in serum and brain of mouse, rat, rabbit, and man.
Marescau B; De Deyn P; Wiechert P; Van Gorp L; Lowenthal A
J Neurochem; 1986 Mar; 46(3):717-20. PubMed ID: 3950603
[TBL] [Abstract][Full Text] [Related]
13. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
Li G; Chu J; Liu X; Yuan Z
Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
[TBL] [Abstract][Full Text] [Related]
14. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.
De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A
Nephron; 1987; 45(4):291-5. PubMed ID: 3587469
[TBL] [Abstract][Full Text] [Related]
15. [Guanidino-succinic acid in uremic patients treated with periodic hemodialysis].
Man NK; Rondon-Nucete M; Kamoun PP; Pleau JM; Zingraff J; Jungers P
J Urol Nephrol (Paris); 1972 Sep; 78(9):750-5. PubMed ID: 4660657
[No Abstract] [Full Text] [Related]
16. [Comparative studies of plasma and urine levels between uremic peak 2a and guanidino compounds].
Koide K; Toyama J; Inoue N; Koshikawa S; Akizawa T; Takahashi K; Hidaka S; Yamane Y; Nakao M; Ono S
Nihon Jinzo Gakkai Shi; 1987 Apr; 29(4):485-92. PubMed ID: 3656706
[No Abstract] [Full Text] [Related]
17. Methylguanidine in uremia.
Giovannetti S; Balestri PL; Barsotti G
Arch Intern Med; 1973 May; 131(5):709-13. PubMed ID: 4701382
[No Abstract] [Full Text] [Related]
18. Uremic concentrations of guanidino compounds inhibit neutrophil superoxide production.
Hirayama A; Noronha-Dutra AA; Gordge MP; Neild GH; Hothersall JS
Kidney Int Suppl; 2001 Feb; 78():S89-92. PubMed ID: 11168990
[TBL] [Abstract][Full Text] [Related]
19. A new automated analytical method for gaunidino compounds and their cerebrospinal fluid levels in uremia.
Yamamoto Y; Saito A; Manji T; Nishi H; Ito K; Maeda K; Ohta K; Kobayashi K
Trans Am Soc Artif Intern Organs; 1978; 24():61-8. PubMed ID: 716068
[No Abstract] [Full Text] [Related]
20. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients.
Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H
Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
